Close Menu

BioReference Laboratories

News items for in vitro diagnostics industry for the week of August 31, 2020.

GeneDx will provide whole-exome and whole-genome sequencing, among other services, to neonatal intensive care units staffed with Pediatrix-affiliated doctors.

Of the 28 companies in the index, 22 firms saw their stock prices increase, while six firms' share prices decreased.

Lab firms are acquiring equipment and implementing approaches like pooled testing, but it remains unclear if this will be enough to meet a fall surge.

Opko's BioReference Laboratories business processed about 2.2 million COVID-19 molecular tests during the quarter, it said.

The firm will provide information on the seroprevalence of SARS-CoV-2, sharing results with demographic information and analysis in collaboration with the CDC.

Even as the broader lab industry struggles to meet SARS-CoV-2 testing needs, many labs focused on nursing homes are unable to benefit from the demand.

News items for the in vitro diagnostics industry for the week of July 13, 2020.

With students and faculty scheduled to return in a few months, institutions are reaching out to secure testing to help keep the virus in check on campus.

Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.